Inion Expands Biodegradable Medical Implant Product Ranges in Europe

CE Mark received for Inion Anchron^TM Suture Anchor

 Tampere, Finland and Takeley, UK. 24 June 2005… Inion [LSE: IIN.L], a rapidly growing company focused on the development of novel biodegradable medical implants, has received a CE Mark for the Inion Anchron^TM Suture Anchor device for both orthopaedic and sports medicine applications. CE Mark is required by a number of accredited bodies to medical device manufacturers prior to commercial distribution in the European Union.

 Inion Anchron^TM is soft tissue repair device that can be used for repairing a range of injuries, particularly in the shoulder. The system can be used in rotator cuff and instability repairs surgery such as Bankart and SLAP lesions.

 Inion produces a full range of sports medicine devices made from Inion’s proprietary Inion OPTIMA^TM range of biomaterials, including Inion Hexalon^TM, the world’s first coloured biodegradable repair device for the cruciate ligaments in the knee; and Inion Trinion^TM, the biodegradable meniscal screw for the repair of torn knee cartilage. Inion Anchron^TM now completes the range ensuring that sports medicine practitioners are able to offer their patients a fully biodegradable alternative for many common sports injuries.

 Dr Auvo Kaikkonen, CEO of Inion commented, "The receipt of this CE Mark and the completion of our sports medicine offering is an important milestone for Inion. It will enable the Company to present a compelling product opportunity to potential distribution partners looking to enhance their own portfolios with a state-of-the-art technology. "

 -Ends- 

 For further information, please contact:

 Inion Oy      

Dr Auvo Kaikkonen, Chief Executive Officer  Tel: +358 3 230 6600

Tim Hirst, Corporate Communications Tel: +44 (0)1279 874 222

Citigate Dewe Rogerson

Mark Swallow / Helena Podd Tel: +44 (0)20 7638 9571 

About Inion (www.inion.com)

Inion Oy is a Finnish company that specialises in the development of biodegradable medical implants. Inion’s core expertise and technology lies in the design and manufacture of innovative biodegradable plates, screws, pins and membranes that are used to enhance the healing of skeletal injuries (bone and soft tissue), such as those caused by trauma or by reconstructive surgery. Inion’s implants are made from its proprietary OPTIMA[TM] family of biomaterials, with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation.

 Inion has developed and launched products in four strategic business areas – cranio-maxillofacial surgery, orthopaedic trauma, sports medicine and dental surgery – in more than 40 countries worldwide, and has a number of international distribution agreements in place, with among others Stryker Corporation and Aesculap (part of B.Braun).

 Inion was incorporated in early 2000 by an international team of experts in biodegradable materials and their clinical applications, and listed on the Official List of the UK Listing Authority in December 2004 (LSE: IIN). The Company’s has corporate headquarters in the UK, R&D and production facilities in Tampere, Finland, and a US office in Oklahoma City, OK.